Showing results (191-200 of 221) with videos related to
Sort By:
Pageof 23
Frontiers in Oncology|February 15, 2021
Next-Generation Sequencing of DDX41 in Myeloid Neoplasms Leads to Increased Detection of Germline AlterationsSarah A Bannon, Mark J Routbort, Guillermo Montalban-Bravo, et al.Cancers|November 13, 2025
Mutational Landscape and Clinical Impact of SPEN Mutations in Patients with Chronic Lymphocytic LeukemiaPriyatharsini Nirmalanantham, Andrés E Quesada, Anindita Ghosh, et al.Pathology|March 18, 2023
Immunophenotypic and genomic landscape of Richter transformation diffuse large B-cell lymphomaSiba El Hussein, L Jeffrey Medeiros, Kirill A Lyapichev, et al.The American Journal of Surgical Pathology|February 13, 2016
Prognostic Factors of Hepatosplenic T-cell Lymphoma: Clinicopathologic Study of 28 CasesMariko Yabe, L Jeffrey Medeiros, Guilin Tang, et al.Nature Communications|May 11, 2021
Leukemia stemness and co-occurring mutations drive resistance to IDH inhibitors in acute myeloid leukemiaFeng Wang, Kiyomi Morita, Courtney D DiNardo, et al.Cancer|April 29, 2021
Clinicopathologic correlates and natural history of atypical chronic myeloid leukemiaGuillermo Montalban-Bravo, Rashmi Kanagal-Shamanna, Koji Sasaki, et al.Blood|March 15, 2014
Atypical chronic myeloid leukemia is clinically distinct from unclassifiable myelodysplastic/myeloproliferative neoplasmsSa A Wang, Robert P Hasserjian, Patricia S Fox, et al.Cancer|June 14, 2017
TP53 mutation does not confer a poor outcome in adult patients with acute lymphoblastic leukemia who are treated with frontline hyper-CVAD-based regimensRashmi Kanagal-Shamanna, Preetesh Jain, Koichi Takahashi, et al.Cancer Discovery|March 26, 2026
Comprehensive Genomic and Transcriptomic Analysis to Guide Therapy for Patients with Metastatic Solid TumorsBurak Uzunparmak, Fei Su, Amber Johnson, et al.Journal of Hematology & Oncology|July 8, 2023
A phase 1/2 study of azacitidine, venetoclax and pevonedistat in newly diagnosed secondary AML and in MDS or CMML after failure of hypomethylating agentsNicholas J Short, Muharrem Muftuoglu, Faustine Ong, et al.Pageof 23